Hofseth BioCare ASA has entered an exclusive license and supply agreement with US-based Fission Holdings for its ProGo® salmon-derived bioactive peptide. Fission will have exclusive worldwide rights to market and sell ProGo® through affiliate and multi-level marketing channels, committing to purchase at least $3 million by January 2027, with projections exceeding $5 million annually. This deal opens a new global consumer channel for ProGo®, complementing Hofseth's existing sales routes. The agreement highlights ProGo®'s clinical benefits for weight management and muscle preservation, leveraging a natural salmon protein source.
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
Alibaba and Baidu shares rose after Apple received approval from China's Cyberspace Administration to include Apple Intelligence, integrating Alibaba's Qwen AI model and Baidu's AI features into Apple devices in China. This partnership allows users t...
